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Abstract 20 
Presynaptic voltage-gated K+ (Kv) channels in dorsal root ganglion (DRG) neurons are thought 21 
to regulate nociceptive synaptic transmission in the spinal dorsal horn. However, the Kv channel 22 
subtypes responsible for this critical role have not been identified. The Kv3.4 channel is 23 
particularly important because it is robustly expressed in DRG nociceptors, where it regulates 24 
action potential (AP) duration. Furthermore, Kv3.4 dysfunction is implicated in the 25 
pathophysiology of neuropathic pain in multiple pain models. We hypothesized that, through 26 
their ability to modulate AP repolarization, Kv3.4 channels in DRG nociceptors help regulate 27 
nociceptive synaptic transmission. To test this hypothesis, we investigated Kv3.4 28 
immunoreactivity (IR) in the rat cervical superficial dorsal horn (sDH) in both sexes, and 29 
implemented an intact spinal cord preparation to investigate glutamatergic synaptic currents from 30 
second order neurons in the sDH under conditions that selectively inhibit the Kv3.4 current. We 31 
found presynaptic Kv3.4 IR in peptidergic and non-peptidergic nociceptive fibers of the sDH. 32 
The Kv3.4 channel is hypersensitive to 4-aminopyridine (4-AP) and tetraethylammonium (TEA). 33 
Accordingly, 50 ?M 4-AP and 500 ?M TEA significantly prolong the AP, slow the maximum 34 
rate of repolarization in small-diameter DRG neurons, and potentiate monosynaptic excitatory 35 
post-synaptic currents (EPSCs) in dorsal horn laminae I and II through a presynaptic mechanism. 36 
In contrast, highly specific inhibitors of BK, Kv7 and Kv1 channels are less effective modulators 37 
of the AP and have little to no effect on EPSCs. The results strongly suggest that presynaptic 38 
Kv3.4 channels are major regulators of nociceptive synaptic transmission in the spinal cord. 39 
Keywords: spinal cord, Kv channel, synaptic transmission, pain transduction   40 
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Significance Statement 41 
Intractable neuropathic pain can result from disease or traumatic injury, and many studies have 42 
been conducted to determine the underlying pathophysiological changes. Voltage-gated ion 43 
channels, including the K+ channel Kv3.4, are dysregulated in multiple pain models. Kv3.4 44 
channels are ubiquitously expressed in the dorsal root ganglion (DRG) where they are major 45 
regulators of DRG excitability. However, little is known about the ionic mechanisms that 46 
regulate nociceptive synaptic transmission at the level of the first synapse in the spinal cord, 47 
which is critical to pain transmission in both intact and pathological states. Here, we show that 48 
Kv3.4 channels have a significant impact on glutamatergic synaptic transmission in the dorsal 49 
horn, further illuminating its potential as a molecular pain therapeutic target. 50 
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Introduction 62 
Glutamatergic synaptic transmission between primary nociceptors and secondary neurons in 63 
superficial layers of the dorsal horn is a critical step in the pain signaling pathway (Tao et al., 64 
2005). However, our understanding of the presynaptic ion channels that regulate this process is 65 
limited (Tsantoulas and McMahon, 2014). Presynaptic voltage-gated K+ (Kv) channels are major 66 
regulators of synaptic transmission because they have a universal ability to regulate excitability 67 
in neural tissues (Dodson and Forsythe, 2004; Bean, 2007). In particular, high voltage-activating 68 
Kv channels shape the repolarization of the AP and, therefore, determine the activation of 69 
voltage-gated Ca++ channels directly involved in vesicular neurotransmitter release at the nerve 70 
terminal. In the CNS, Kv3 channels are the best candidates to play this role (Rudy and McBain, 71 
2001; Ishikawa et al., 2003; Dodson and Forsythe, 2004; Goldberg et al., 2005; Kaczmarek and 72 
Zhang, 2017; Liu et al., 2017). Recent work conclusively demonstrated that Kv3.1/3.4 73 
heteromultimers regulate AP duration in boutons of cerebellar stellate inhibitory interneurons 74 
and, thereby, help determine evoked neurotransmitter release (Rowan et al., 2014, 2016; Rowan 75 
and Christie, 2017). However, whether a similar complex regulates nociceptive glutamatergic 76 
transmission in the spinal cord dorsal horn is not known. Also, it is important to know how cell 77 
signaling pathways associated with nociception might modulate key presynaptic Kv channels 78 
(Trimmer, 2014). 79 
 Previous work reported expression of multiple Kv channels, including Kv3.4, in adult 80 
DRG neurons (Gold et al., 1996; Rasband et al., 2001; Brooke et al., 2004a; Chien et al., 2007; 81 
Ritter et al., 2012, 2015a; Trimmer, 2014; Tsantoulas and McMahon, 2014; Liu et al., 2017). We 82 
have also determined that homomultimeric Kv3.4 channels underlie the majority of the high-83 
voltage-activating K+ current in small-diameter dorsal root ganglion (DRG) neurons (Ritter et al., 84 
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2012, 2015b). Supporting this assessment, we found robust expression of Kv3.4 mRNA in these 85 
neurons, which dominates the small to negligible expression of the Kv3.1, Kv3.2 and Kv3.3 86 
mRNAs (Ritter et al., 2012). Additionally, siRNA knockdown nearly abolishes the Kv3.4 current 87 
in small-diameter DRG neurons and prolongs the duration of the action potential (AP), helping 88 
demonstrate that Kv3.4 channels are major regulators of AP repolarization in the DRG (Ritter et 89 
al., 2012, 2015b). Moreover, Kv3.4 channels enhance their activity by undergoing switching 90 
from fast-inactivating A-type to slow-inactivating delayed rectifier-type upon phosphorylation of 91 
several serines within the channel’s N-terminal inactivation domain (NTID) (Covarrubias et al., 92 
1994; Beck et al., 1998; Antz et al., 1999; Ritter et al., 2012; Zemel et al., 2017). In small-93 
diameter DRG neurons, this mechanism shortens the AP, strongly suggesting that Kv3.4 channel 94 
activity drives repolarization of APs carrying nociceptive signaling (Ritter et al., 2012; Liu et al., 95 
2017). Therefore, we hypothesized that Kv3.4 channels might ultimately determine nociceptive 96 
signaling at the level of the superficial dorsal horn (sDH) by regulating AP shape and duration, 97 
which would govern Ca++–dependent glutamatergic vesicular release and the resulting excitatory 98 
postsynaptic current. 99 
 To test this hypothesis, we investigated Kv3.4 immunoreactivity (IR) in the sDH, which 100 
receives A??and C-fiber (nociceptive fiber) projections. Then, to probe the electrophysiological 101 
impact of the Kv3.4 channel, we implemented an ex vivo preparation of an intact cervical spinal 102 
cord, a method suitable for patch-clamp recordings from superficial second order dorsal horn 103 
neurons that receive nociceptive inputs. Under conditions that stimulate A??and C-fibers, we 104 
tested the effects of relatively specific K+ channel inhibitors on the magnitude of excitatory 105 
postsynaptic currents (EPSCs). Along with robust presynaptic Kv3.4 IR in the sDH, the 106 
electrophysiological results demonstrate that preferential inhibition of presynaptic Kv3.4 107 
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channels potentiates EPSCs in the sDH. Consistent with the hypothesis, inhibition of somatic 108 
Kv3.4 channels in the DRG also prolongs the AP by slowing the maximum rate of 109 
repolarization. The identification of the Kv3.4 channel as a significant player in the pain 110 
signaling pathway has implications in the pathophysiology of neuropathic pain induced by spinal 111 
cord injury and other nervous system diseases (Ritter et al., 2015a, 2015b; Zemel et al., 2017).   112 
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 128 
Materials and Methods 129 
Spinal cord preparation 130 
All animals were treated as approved by the IACUC of Thomas Jefferson University. Time-131 
pregnant female Sprague–Dawley rats (Taconic Farms) were maintained in the Thomas Jefferson 132 
University Animal Facility for 1 week prior to the birth of pups. For all experiments, rat pups 133 
were killed by overdose of ketamine (380 mg/kg), xylazine (40 mg/kg), and acepromazine 134 
(0.3mg/kg) followed by decapitation. Cervical spinal cords were harvested from P9-P30 rat pups 135 
of either sex in a similar manner as described in previous studies (Pinto et al., 2008, 2010; Szucs 136 
et al., 2009). The spinal column was rapidly removed and placed in dissecting artificial cerebral 137 
spinal fluid (dACSF) consisting of (in mM): 220 Sucrose, 25 NaHCO3, 11 Glucose, 2.5 KCl, 0.5 138 
CaCl2, 7 MgCl2 and 1.25 NaH2PO4 at room temperature, and bubbled with a 95% O2/5% CO2 139 
gas mixture to oxygenate and adjust pH (7.3-7.4). The spinal column was pinned down with the 140 
ventral side facing up and the ventral bony laminae were removed to expose the underlying 141 
spinal cord. The dorsal roots in the cervical region are around 1-3 mm therefore dorsal root 142 
ganglia (DRG) attached to the dorsal roots were dissected out of the bony cavity intact in order 143 
to preserve as much root as possible for stimulation. Generally, segments C5-C8 were used for 144 
all experiments. The spinal cord with attached dorsal roots and DRGs was carefully lifted out of 145 
the spinal column and the cervical spinal cord region was trimmed from the rest of the cord. The 146 
dura mater was removed and ventral roots cut from the cord to reflect the dorsal roots medially, 147 
thereby exposing a strip of gray matter on the dorsolateral side of the cord corresponding to the 148 
dorsal horn. The pia mater was gently peeled off from the region of interest in order to allow 149 
access for patch electrodes and the DRG was removed from the dorsal root. The cleaned and 150 
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trimmed cervical spinal cord was then pinned onto a beveled piece of elastomer compound eraser 151 
at an angle of ~15o (Fig 3A) and transferred to an incubation chamber with oxygenated artificial 152 
cerebral spinal fluid (ACSF) consisting of (in mM): 115 NaCl, 25 NaHCO3, 11 Glucose, 3 KCl, 153 
2 CaCl2, 1 MgCl2, and 1 NaH2PO4 at room temperature until ready to transfer to the patch-clamp 154 
recording chamber. Compared to previous studies using this preparation, the use of 155 
cyanoacrylate glue was exempted in favor of small pins to keep the cord at the desired angle for 156 
illumination. Additionally, this configuration allowed us to straighten out the natural curvature of 157 
the cervical cord.  158 
Dorsal horn neuron illumination and visualization 159 
Neurons in the dorsal horn were illuminated using oblique infrared light-emitting diodes (LED)  160 
and visualized using a RolerA-XR camera and Q-Capture Pro7 software (Pinto et al., 2008, 161 
2010; Szucs et al., 2009; Hachisuka et al., 2016). The LED was mounted on a small 162 
micromanipulator (Narishige) placed on the microscope headstage, and the x-y-z axes were 163 
adjusted until maximal contrast was achieved. Still images were taken using the Q-Capture Pro7 164 
software. Neurons were selected for recording based on their location in laminae I and II of the 165 
superficial dorsal horn. 166 
Preparation of acutely dissociated DRG neurons 167 
P7-P28 pups were killed as mentioned for spinal cord experiments and ganglia were harvested 168 
from all accessible levels and placed into Hanks’ buffered saline solution (HBSS) with 10 mM 169 
HEPES. Ganglia were dissociated by treatment with 1.5 mg/mL collagenase in HBSS/HEPES 170 
solution for 30 min followed by a 15-20 min treatment with 1 mg/mL trypsin in HBSS/HEPES 171 
solution. DRG neurons were then transferred to L-15 Leibovitz medium supplemented with 10% 172 
fetal bovine serum, 2 mM L-glutamine, 24 mM NaHCO3, 38 mM glucose, and 2% penicillin-173 
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streptomycin and mechanically dissociated with a fire polished Pasteur pipette. Neurons were 174 
plated onto poly L-ornithine coated coverslips and kept at 37oC for up to 48 h. 175 
Electrophysiology 176 
Patch electrodes were made from Corning 7056 thin wall capillary glass (Warner Instruments) 177 
and pulled with a PIP5 micropipette puller (HEKA Instruments Inc) or a P-97 micropipette puller 178 
(Sutter Instruments). Electrodes were fire polished to have tip resistances of 1–4 MΩ. Signals 179 
were amplified using a Multiclamp 700B amplifier (Molecular Devices), low-pass filtered at 2 180 
kHz (4-pole Bessel), digitized at 10 kHz (Digidata 1440, Molecular Devices), and stored in a 181 
computer using Clampex 10.2 (Molecular Devices). Spinal cord recordings were obtained at 182 
room temperature in oxygenated ACSF and the internal pipette solution consisted of (in mM): 183 
150 K-gluconate, 3 KCl, 1 MgCl2, 1 EGTA, 10 HEPES, pH 7.3 with KOH. All spinal cord 184 
voltage-clamp recordings were conducted at holding potentials (VH) between -70 and -80 mV, 185 
the empirically determined reversal potential of Cl-, in order to minimize detection of any 186 
inhibitory post-synaptic currents. In some instances, recorded neurons were labeled using an 187 
Alexa Fluor-conjugated biocytin marker (Thermo Fisher) for visualization. A suction electrode 188 
was used to stimulate the dorsal root using an A-M Systems isolated pulse stimulator, model 189 
2100. Typically, the dorsal roots were 1-3 mm in length and stimulated with pulses in the range 190 
of 100-600 μA, duration of 1 ms, and frequency of 0.1-1 Hz. Recordings of monosynaptic 191 
EPSCs were those that had no failures upon stimulation. Only monosynaptic EPSCs were chosen 192 
for further analysis. 193 
Action potential experiments were performed on small-diameter DRG neurons (≤25 μm) 194 
as previously reported (Ritter et al., 2012, 2015a; Zemel et al., 2017).  In these experiments, the 195 
external solution consisted of (in mM): 130 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, and 10 HEPES 196 
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while the internal solution consisted of: 130 K-MES, 1 CaCl2, 1 EGTA, 10 HEPES, 2 Mg-ATP, 197 
and 0.3 Tris-GTP. Liquid junction potential (+15.2 mV for spinal cord recordings and +15.5 mV 198 
for DRG recordings) were calculated using Clampex version 10.5 software and were corrected 199 
offline. 200 
Drugs and toxins 201 
All toxins and drugs were stored as concentrated stocks and added to the recording solution 202 
immediately prior to recording. Tetraethylammonium-Cl (TEA; Sigma), 4-aminopyridine (4-AP; 203 
Sigma), α-dendrotoxin (α-DTX; Alomone), iberiotoxin (IbTX; Smartox) and 6-cyano-7-204 
nitroquinoxaline-2,3-dione (CNQX disodium salt; Alomone) were dissolved in deionized water 205 
and XE991 (Alomone) was dissolved in DMSO. For DRG experiments, a 100 mM 4-AP stock 206 
solution was made and the pH was adjusted to ~7.4 with HCl prior to use. 207 
Immunohistochemistry 208 
Animals were killed as previously described and transcardially perfused with 0.9% saline 209 
followed by 4% paraformaldehyde (Ritter et al., 2015a; Zemel et al., 2017). Cervical spinal cords 210 
were harvested and stored in 4% paraformaldehyde (1 day), followed by 0.1 M phosphate buffer 211 
(1 day), and finally in 30% sucrose containing phosphate buffer (>3 days). The tissue was then 212 
embedded in tissue freezing medium and 30 μm sections were cut. Sections were collected on 213 
glass slides and stored until further use. 214 
Immunohistochemistry procedures were carried out at room temperature. The slides with 215 
the sections were washed with PBS three times (5 minutes each). Sections were then blocked 216 
with 10% normal goat serum (NGS) in PBST (PBS containing 0.2% TritonX-100) for 1 hour and 217 
then incubated with guinea pig anti-CGRP (1:1000, BMA Biomedicals), rabbit anti-Kv3.4 218 
(1:100, Alomone) or guinea pig anti-VGLUT2 (1:2000, Millipore) overnight at room 219 
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temperature. Sections were then washed three times (5 minutes each) and incubated with goat 220 
anti-rabbit Alexa Fluor 488 (1:150, Abcam) or goat anti-guinea pig Alexa Fluor 568 (1:500, 221 
Thermo Fisher) in 5% NGS in PBST for 1 hour at room temperature. The sections were then 222 
again washed with PBS three times (5 minutes each) and coverslips were added with FluorSave 223 
reagent (Calbiochem). Finally, the slides were allowed to dry at room temperature overnight and 224 
stored at 4?? C. For double immunostaining of Kv3.4 and IB4, Alexa Fluor 594 conjugated 225 
isolectin GS-IB4 (2 μg/ml, Thermo Fisher) was incubated for 30 minutes after completion of 226 
overnight primary and secondary antibody treatment for Kv3.4 alone. The sections were imaged 227 
on a FluoView FV1000 confocal microscope (Olympus). 228 
Data analysis and statistics 229 
Data processing and analysis were conducted in Clampfit 10.5 (Molecular Devices) and Origin 230 
Pro 9.1 (OriginLab Corp). Student’s paired t-test was used to evaluate differences in paired data 231 
sets. Details of the statistical analyses are provided in the corresponding figure legends and exact 232 
p values are generally shown on the graphs. Phase plane plots for nociceptor action potentials 233 
were obtained by plotting the 1st derivative of the AP waveform vs. the membrane potential of 234 
the AP waveform, which allows visualization of rate changes as a function of voltage. Values for 235 
means are presented as Mean ± SEM (standard error of the mean) throughout. 236 
 237 
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Results  246 
Spinal cord Kv3.4 channels are present in presynaptic peptidergic and non-peptidergic 247 
nociceptive fibers of the sDH 248 
To probe the functional role of the Kv3.4 channel on nociceptive spinal synaptic signaling, it is 249 
important to demonstrate presynaptic Kv3.4 expression in the sDH. We conducted 250 
immunohistochemical analyses in rat pup spinal cord to assess the expression of Kv3.4, several 251 
markers of nociceptors (CGRP and IB4) and an established marker of the excitatory presynaptic 252 
compartment (VGLUT2) (Materials and Methods). We observed Kv3.4 immunoreactivity in 253 
dorsal horn laminae I-III, where it co-localized with peptidergic calcitonin gene-related peptide 254 
(CGRP) and non-peptidergic isolectin B4 (IB4) nociceptive fibers (Fig. 1A-C, Fig. 2A-C). 255 
Additionally, Kv3.4 immunoreactivity co-localized with the presynaptic glutamatergic marker 256 
VGLUT2 (Fig. 2D). Thus, Kv3.4 channels are expressed presynaptically in sDH laminae where 257 
it co-localizes with known markers of nociceptive primary afferents.  258 
Characterization of cervical sDH neurons in an intact spinal cord preparation  259 
To investigate spinal nociceptive synaptic transmission under conditions that preserve the 260 
integrity of neural circuitry in the cervical spinal cord, we implemented and characterized an 261 
optimized intact preparation previously developed to study the lumbar and thoracic regions 262 
(Pinto et al., 2008, 2010; Szucs et al., 2009). The cervical spinal cord presented a few challenges 263 
because of the short roots (1-3 mm) and cervical flexure (Materials and Methods). A bipolar 264 
suction electrode applied to the selected dorsal root (C5-C8) was used for electrical stimulation 265 
and oblique LED illumination allowed visualization of sDH neurons (Materials and Methods; 266 
Fig. 3A-B). We selected spinal cord neurons based on their location in laminae I or II of the 267 
sDH, and conducted whole-cell patch-clamp recordings using standard methods as previously 268 
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described (Fig. 3C-F; Materials and Methods) (Pinto et al., 2008, 2010; Szucs et al., 2009). Upon 269 
preferential electrical stimulation of C and A? fibers of the dorsal root (100-600 ?A, 1 ms, 0.1 270 
Hz), these neurons displayed robust monosynaptic evoked EPSCs (eEPSCs) sensitive to CNQX 271 
(1 μM), which indicates excitatory glutamatergic synaptic transmission most likely associated 272 
with nociceptive signaling (Fig 3E; Table 1). In the absence of stimulation, and at a holding 273 
potential approximately equal to the Cl- reversal potential (to nullify inhibitory synaptic 274 
currents), these neurons also exhibited spontaneous CNQX-sensitive EPSCs (sEPSCs) resulting 275 
from spontaneous quantal release of glutamate from C and A? fibers and interneurons synapsing 276 
on the nociceptive laminae of the sDH (Fig. 3F). Correspondingly, under current-clamp 277 
conditions and following stimulation of the dorsal roots, we observed sub- and supra-threshold 278 
EPSPs (Fig. 4A-B). Further supporting the healthy quality of the spinal cord preparation, the 279 
selected neurons also exhibited robust passive and active membrane parameters (Fig. 4C-D; 280 
Table 2). 281 
Evoked EPSCs in the sDH are potentiated by TEA and 4-AP but not by antagonists of BK, Kv7, 282 
and Kv1 channels 283 
Following the demonstration of Kv3.4 channel expression in presynaptic nerve terminals of the 284 
spinal cord dorsal horn and physiological validation of the intact spinal cord preparation, we set 285 
out to determine whether this Kv channel is a regulator of synaptic transmission in the sDH. Kv3 286 
channels are hypersensitive to low, submillimolar concentrations of the well-known K+ channel 287 
blockers, 4-AP and TEA (Schroter et al., 1991; Vega-Saenz de Miera et al., 1992). To test the 288 
effects of these inhibitors on synaptic transmission, we held the membrane potential of the spinal 289 
cord neuron at -70 mV (~ECl) and recorded eEPSCs upon strong stimulation of the dorsal root 290 
(100-600 ?A) to excite high-threshold nociceptive fibers (C and A?).  Under these conditions, 291 
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the recorded eEPSC results from activation of spinal cord glutamatergic AMPA receptors (Fig. 292 
3). Exposure to either 50 μM 4-AP or 500 μM TEA similarly potentiated the average peak of the 293 
eEPSCs by 47.14 ± 18.69% and 20.71 ± 8.19%, respectively (Fig. 5A-B). These results suggest 294 
that, through inhibition of presynaptic C/A? fiber K+ channels, the presynaptic AP is prolonged 295 
and, consequently, vesicular Ca++–dependent glutamatergic release is enhanced.  296 
However, this result alone cannot rule out possible contributions of other K+ channels 297 
that are also significantly sensitive to TEA and/or 4-AP, such as Kv1, Kv7, and big-conductance 298 
Ca++–activated K+ (BK) channels (Dodson and Forsythe, 2004). Expression of these K+ channels 299 
has also been reported in putative DRG nociceptors (Everill et al., 1998; Scholz et al., 1998; 300 
Rasband et al., 2001; Beekwilder et al., 2003; Zhang et al., 2003, 2010; Chi and Nicol, 2007; 301 
Rose et al., 2011; Zheng et al., 2013; Martinez-Espinosa et al., 2015; Liu et al., 2017).  To rule 302 
out whether these K+ channels were contributing to the observed TEA and 4-AP effects, we 303 
tested α-DTX, XE991, and IbTX which are highly selective antagonists of Kv1.1/1.2/1.6, Kv7 304 
and BK channels, respectively. Upon exposing spinal cords to these antagonists, we observed no 305 
effect on the average peak of the eEPSCs, which is in contrast to the potentiating effects of TEA 306 
and 4-AP (Fig. 6A-C). Also, α-DTX, XE991 and IbTX have little to no effect on jitter and rise 307 
time of the eEPSCs (Table 3). Given the differential effects of TEA and 4-AP against the other 308 
more specific K+ channel antagonists, we can conclude that inhibition of a Kv3-type channel is 309 
most likely responsible for the associated potentiation of the eEPSCs. Furthermore, Kv3.4 is the 310 
top candidate. Besides its presynaptic expression in nociceptive afferents of the sDH (Fig. 1-2), 311 
we have previously reported strong evidence demonstrating that Kv3.4 is the dominant Kv3 312 
isoform in putative DRG nociceptors from rat pups (Ritter et al., 2012, 2015a, 2015b).  313 
TEA and 4-AP act presynaptically to potentiate the eEPSC 314 
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The results so far are consistent with a presynaptic role of the Kv3.4 channel. However, the 315 
average peak eEPSC resulting from consecutive stimulations might include both monosynaptic 316 
and polysynaptic responses. Confirming that low concentrations of TEA and 4-AP potentiate 317 
monosynaptic eEPSCs would add strong support to a presynaptic DRG mechanism involving 318 
regulation of the AP by Kv3.4. Thus, from each stimulation run (a family of traces), we isolated 319 
consistent stable EPSC peaks (no failures) in each individual trace by-eye, segments which 320 
oftentimes coincided with the lowest variance around the peak (Fig. 7). Both methods 321 
consistently revealed similar monosynaptic peaks in individual traces, which were generally 322 
potentiated by low concentrations of TEA and 4-AP (Fig. 8A-B). By contrast, IbTX, α-DTX and 323 
XE991 had little to no effect on monosynaptic eEPSC peaks (Fig. 8C-E).  324 
 To test the presynaptic mechanism further, we also investigated the effects of the K+ 325 
channel antagonists on the paired pulse ratio (PPR) and the amplitude of spontaneous EPSCs 326 
(sEPSC). A change in the PPR demonstrates a presynaptic effect tied to vesicle depletion 327 
inducing synaptic depression (PPR=P2/P1<1) or presynaptic Ca2+ accumulation associated with 328 
synaptic facilitation (PPR>1) (Fioravante and Regehr, 2011). In contrast, no PPR change would 329 
be more consistent with a postsynaptic effect that impacts paired responses equally. Generally, 330 
we found that the PPR was <1 under control conditions, indicating synaptic depression.  In the 331 
presence of 4-AP and TEA, the PPR was consistently decreased further (0.79 ± 0.23 to 0.58 ± 332 
0.24 for 4-AP, 0.69 ± 0.11 to 0.48 ± 0.11 for TEA), which suggests exacerbated vesicle depletion 333 
resulting from a presynaptic effect of the inhibitors (Fig. 9A-B). 334 
Desensitization of postsynaptic AMPA receptors could have contributed to the observed 335 
synaptic depression (Kirischuk et al., 2002; Chen et al., 2004; Christie et al., 2010). Thus, to 336 
directly assess a possible postsynaptic phenomenon, we examined the effect of TEA on the 337 
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amplitude of sEPSCs. The origin of the sEPSCs includes vesicle release from primary DRG 338 
nociceptive afferents and spinal interneurons. To isolate the sEPSCs mainly mediated by AMPA 339 
receptor channels, we recorded the spontaneous activity at ECl (-70 mV), as done previously (Fig. 340 
3).  We observed significant spontaneous activity, which allowed robust measurements of sEPSC 341 
peak amplitudes before and after exposure to 500 ?M TEA (>400 events; Fig. 10A).  In three 342 
independent paired experiments, we found that the normalized amplitude histograms of the 343 
sEPSCs recorded before and after exposure to TEA were indistinguishable (Fig. 10B-C). These 344 
results ruled out a postsynaptic action of TEA, which could have been responsible for the TEA-345 
dependent potentiation of the eEPSCs. Additionally, there was no change in the frequency of 346 
events before and after exposure to 500 ?M TEA (6.22 ± 2.59 events/sec and 6.54 ± 3.37 347 
events/sec, before and after TEA, respectively; estimates derived from data presented in Fig 10), 348 
demonstrating that TEA did not impact the level of spontaneous activity, a proxy measurement 349 
for presynaptic resting membrane potential. Based on the evidence provided by three 350 
independent experiments (monosynaptic potentiation, enhanced synaptic depression and lack of 351 
effect on sEPSC amplitude and frequency), we conclude that submillimolar 4-AP and TEA 352 
potentiate glutamatergic synaptic transmission at a presynaptic level thorough the inhibition of 353 
Kv3.4 channels in DRG neurons. 354 
The DRG action potential is consistently modulated by the Kv channel inhibitors TEA and 4-AP 355 
If presynaptic potentiation of the eEPSC results from prolonging the presynaptic AP upon 356 
inhibition of the Kv3.4 current in DRG neurons, we expected broadening of the somatic AP by 357 
submillimolar TEA and 4-AP and little and inconsistent effects of IbTX, α-DTX, and XE991 on 358 
somatic AP duration. This hypothesis, however, assumes that the somatic and presynaptic APs 359 
are shaped by a similar ensemble of ion channels and, therefore, similarly regulated by Kv3.4. 360 
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To test these ideas, we recorded somatic APs from acutely dissociated DRG neurons before and 361 
after the exposure to the selected K+ channel inhibitors at the same concentrations used in the 362 
spinal cord recordings (Fig. 11; Table 4). Whereas TEA and 4-AP consistently broadened the AP 363 
(APD50 and APD90; p = 4.99E-4 – 0.042) and slowed the maximum rate of repolarization (p = 364 
6.99E-4 – 0.037), the effects of IbTX on these properties were inconsistent, albeit it marginally 365 
prolonged the APD50 (p = 0.043). By contrast, XE991 and α-DTX did not affect the AP 366 
waveform (Fig 11; Table 4). Overall, these results are consistent with a major direct role of 367 
Kv3.4 on the repolarization of the AP in DRG neurons, which secondarily regulates evoked 368 
Ca++-dependent glutamatergic neurotransmission in the sDH of the spinal cord. The inconsistent 369 
results with IbTX, suggest heterogeneity and quantitative differences in the relative contributions 370 
of Kv3.4 and BK channels to AP repolarization in the soma and nerve terminals of putative 371 
nociceptors. 372 
373 
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Discussion  374 
The Kv3.4 channel is a major regulator of AP repolarization in small-diameter nociceptors in the 375 
DRG. Here, we asked whether this regulation actually impacts nociceptive signaling in the spinal 376 
cord. Consistent with a presynaptic localization, we found that Kv3.4 is expressed in excitatory 377 
presynaptic terminals in nociceptive afferents of the sDH, where it co-localizes with key 378 
molecular markers of the pain pathway (CGRP, IB4 and VGLUT2). Using an ex vivo 379 
preparation of the cervical spinal cord and several K+ channel inhibitors, we demonstrate that 380 
submillimolar concentrations of 4-AP and TEA potentiate monosynaptic glutamatergic eEPSCs, 381 
suggesting that inhibition of the presynaptic 4-AP/TEA-hypersensitive Kv3.4 is responsible for 382 
this potentiation. Strengthening this conclusion, these inhibitors also decreased the PPR but did 383 
not affect the amplitude and frequency of sEPSCs. By contrast, specific inhibition of other DRG 384 
K+ channels that also exhibit hypersensitivities to 4-AP and/or TEA did not affect the eEPSC. 385 
Further supporting a direct relationship between Kv3.4-dependent regulation of AP duration in 386 
the DRG and the eEPSC peak in the sDH, submillimolar TEA and 4-AP prolong the presynaptic 387 
AP, whereas other specific K+ channel inhibitors induce little and inconsistent effects on the AP 388 
waveform. 389 
Optimization of the ex vivo cervical spinal cord patch-clamping technique 390 
Over the last decade, several studies have used intact organ spinal cord preparations to study 391 
electrophysiological and morphological parameters as well as local circuitry (Pinto et al., 2008, 392 
2010; Szucs et al., 2009; Hachisuka et al., 2016). Compared to traditional slices, this technique 393 
has many advantages, including less damage to the spinal cord, which is especially important 394 
toward understanding the complex circuitry of the dorsal horn (Peirs and Seal, 2016). However, 395 
this technique has thus far been mainly applied to the lumbar and thoracic regions of the spinal 396 
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cord. The cervical spinal cord is important not only from a physiological perspective, but also 397 
from a relevant pathological viewpoint since the cervical region is the most common location of 398 
spinal cord injuries in humans. Thus, we focused on optimizing this preparation to expand the 399 
application and relevance of the ex vivo spinal cord technique. By minimizing the pronounced 400 
flexure of the cervical region and ensuring the viability of short dorsal roots, we obtained a 401 
robust and reliable new preparation suitable for intact spinal cord patch clamping experiments. 402 
The presynaptic Kv3.4 channel regulates glutamatergic signaling in the superficial dorsal horn 403 
Consistent with previous reports (Brooke et al., 2004a; Chien et al., 2007), we observed Kv3.4 404 
expression in the neuropil of the sDH, where it co-localizes with markers of nociceptive fibers, 405 
CGRP and IB4. Additionally, our new results show that Kv3.4 found in the sDH is expressed 406 
presynaptically in glutamatergic axonal terminals, as determined by its co-localization with 407 
VGLUT2. Thus, Kv3.4 is ideally present in the terminal axonal compartment to regulate 408 
nociceptive synaptic transmission through its ability to shape AP repolarization. 409 
 Generally, presynaptic Kv channels help tune synaptic transmission by regulating the 410 
spiking properties of neurons (Dodson and Forsythe, 2004; Kaczmarek and Zhang, 2017). This 411 
information coupled with previous work demonstrating that Kv3 channels are the primary 412 
regulators of AP repolarization in the CNS and that Kv3.4 is the dominant Kv3 channel in DRG 413 
neurons, suggests that this ion channel might play a significant role as a regulator of nociceptive 414 
synaptic activity at the level of the first synapse in the pain pathway (Goldberg et al., 2005; 415 
Ritter et al., 2012; Rowan et al., 2014, 2016; Liu et al., 2017; Rowan and Christie, 2017). New 416 
data described here strongly support this hypothesis by demonstrating that a Kv channel 417 
hypersensitive to 4-AP and TEA, such as Kv3.4, regulates AP repolarization rate and duration in 418 
nociceptors and, consequently, the amplitude of the eEPSC in the sDH. 419 
  21 
Since the Kv3.4 channel’s main role is to help repolarize the AP in small-diameter DRG 420 
neurons, its inhibition would prolong the AP that ultimately reaches the nerve terminal of 421 
putative nociceptors. Thus, if the AP evoked by electrical stimulation of the dorsal root is 422 
prolonged following inhibition of the Kv3.4 channel by either TEA or 4-AP, activation of 423 
voltage-gated Ca++ channels and the resulting Ca++ entry into the nerve terminal are increased. 424 
Consequently, the probability of Ca++-dependent vesicular glutamate release increases and the 425 
ensuing eEPSC is potentiated, which is in line with accepted theories of quantal 426 
neurotransmission (Katz and Miledi, 1967; Mulkey and Zucker, 1991; Llinás et al., 1992; Borst 427 
et al., 1995; Bollmann and Sakmann, 2005). The results of this work are reminiscent of the role 428 
that presynaptic Kv3.4 might play at the mouse neuromuscular junction, where inhibition of this 429 
ion channel potentiates the endplate potential (Brooke et al., 2004b). Also, the interpretation of 430 
our results gains additional support from the pattern of differential effects that K+ channel 431 
inhibitors have on the AP waveform in the DRG, which generally mirrors the effects on the 432 
eEPSC in the sDH. In particular, however, there are interesting differences possibly reflecting 433 
quantitatively different contributions of distinct K+ channels to AP repolarization in the soma 434 
and the nerve terminal. For instance, it appears that IbTX is capable of prolonging the AP by 435 
mainly increasing the APD50, but it has no consistent effect on the eEPSC. By contrast, 436 
submillimolar 4-AP and TEA consistently lengthen the APD50 and APD90, and accordingly 437 
potentiate the monosynaptic eEPSC. The DRG AP results are consistent with previous studies 438 
(Li et al., 2007; Zhang et al., 2010; Liu et al., 2017). 439 
 To establish that the mechanism discussed above most likely involves presynaptic 440 
regulation by Kv3.4, submillimolar TEA and 4-AP also enhanced synaptic depression by 441 
decreasing the PPR. This is likely the result of increased vesicle depletion. Moreover, we found 442 
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no evidence of a postsynaptic contribution because the amplitude of spontaneous EPSCs was not 443 
affected by submillimolar TEA. Also, TEA had no effect on the spontaneous EPSC frequency, 444 
which, under the conditions of our experiments, might originate from spontaneous release and 445 
evoked release resulting from spontaneous depolarizations originating in the DRG and spinal 446 
interneurons. Thus, TEA-hypersensitive K+ channels are not regulating resting membrane 447 
potential (Table 4) and spontaneous spiking, which is consistent with the interpretation of our 448 
results. Kv3.4 is a high voltage-activating A-type Kv channel that is best suited to shape AP 449 
repolarization, as established by recent work from us and others (Ritter et al., 2012; Rowan et al., 450 
2014, 2016; Liu et al., 2017; Rowan and Christie, 2017). 451 
The role of other K+ channels expressed in the DRG 452 
The DRG expresses multiple K+ channels exhibiting differential cellular and subcellular 453 
distributions in heterogeneous populations of primary sensory neurons and, moreover, they share 454 
major differences in terms of their gating properties and mechanisms of modulation (Gold et al., 455 
1996; Safronov et al., 1996; Rasband et al., 2001; Zhang et al., 2003, 2010; Chi and Nicol, 2007; 456 
Chien et al., 2007; Phuket and Covarrubias, 2009; Duan et al., 2012; Zheng et al., 2013).  Thus, 457 
they play a myriad of roles along the peripheral sensory pathway, regulating resting membrane 458 
potential and AP properties (shape, repolarization rate, propagation, latency to first spike, 459 
interspike interval, afterhyperpolarization, etc.). By using a battery of specific K+ channel 460 
antagonists (α-DTX, XE991, IbTX) against DRG K+ channels sharing sensitivities to 461 
submillimolar concentrations of TEA and/or 4-AP, we ruled out major possible contributions of 462 
several DRG K+ channels (Kv1.1, Kv1.2, Kv1.6, Kv7 and BK channels) to nociceptive synaptic 463 
transmission in the sDH.  Although BDS-I is thought to be a specific Kv3.4 peptide inhibitor, we 464 
did not use it in these experiments, because it also potentiates Nav1.7 with high potency, a 465 
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critical voltage-gated Na+ channel expressed in primary sensory neurons (Diochot et al., 1998; 466 
Liu et al., 2012). It is also unlikely that DRG Kv1.4 and Kv4 channels contribute presynaptically 467 
to synaptic transmission in the sDH because they are low voltage-activating, highly resistant to 468 
TEA, and only modestly sensitive to 4-AP. Furthermore, the expression of Kv4.1 and Kv4.3 is 469 
limited to the soma of rat DRG neurons (Gold et al., 1996; Chien et al., 2007; Phuket and 470 
Covarrubias, 2009; Yunoki et al., 2014). Additionally, other channels, such as Kv2 and Slack 471 
channels, are also expressed in the DRG but are unlikely to be candidates because they are 472 
relatively insensitive to TEA and 4-AP (Patel et al., 1997; Bocksteins et al., 2009; Lu et al., 473 
2015). Overall, these results strongly suggest that Kv3.4, the most likely target of submillimolar 474 
TEA and 4-AP, is a major presynaptic regulator of excitatory neurotransmission from 475 
glutamatergic C- and A?-fibers in the sDH.  476 
Implications and Perspective 477 
Previous work and the new results presented here collectively constitute compelling evidence for 478 
the presynaptic role of the Kv3.4 channel as a significant regulator of glutamatergic synaptic 479 
signaling in the spinal cord nociceptive pathway. These findings help explain how SCI-induced 480 
dysfunction of the Kv3.4 channel in primary nociceptors can lead to intractable neuropathic pain. 481 
Thus, the Kv3.4 channel is an attractive target that might help develop more effective 482 
interventions to alleviate persistent pain induced by SCI and other nervous system diseases 483 
associated with pathological pain. Any manipulations that increase Kv3.4 activity in the DRG 484 
might have beneficial analgesic effects. 485 
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Figure Legends 709 
 710 
Figure 1. Co-localization of the Kv3.4 channel with the peptidergic nociceptive marker 711 
calcitonin gene-related peptide (CGRP). Immunohistochemical staining demonstrating co-712 
labeling of CGRP with Kv3.4 protein. Panels B and C are magnified areas of panel A. 713 
 714 
Figure 2. Co-localization of the presynaptic Kv3.4 channel with the non-peptidergic 715 
nociceptive marker isolectin B4 (IB4). (A)-(C) Immunohistochemical staining demonstrating 716 
co-labeling of IB4 with Kv3.4 protein. Panels B and C are magnified areas of panel A. (D) Co-717 
labeling of Kv3.4 protein with the glutamatergic presynaptic marker VGLUT2. 718 
 719 
Figure 3. Intact cervical spinal cord preparation for patch-clamp recordings of 720 
glutamatergic synaptic currents from the superficial dorsal horn. (A) Schematic of the 721 
experimental set-up representing its main components. Neurons in the superficial dorsal horn are 722 
visualized using oblique infrared LED illumination and a 40x immersion objective. SC = spinal 723 
cord pinned at an angle of 10o – 15o on a piece of elastomer compound eraser. The spinal cord is 724 
represented by a cross section of the cervical region with its axis perpendicular to the plane of 725 
the image. BSE = bipolar stimulation electrode (suction electrode). DR = dorsal roots (one free 726 
and the other inside the suction electrode). PCE: patch-clamping electrode hooked up to a 727 
Multiclamp 700B amplifier. (B). Images of lamina I neurons subjected to whole-cell patch-728 
clamping. Top, infrared image; bottom, fluorescence image of neuron loaded with biocytin 729 
(conjugated with Alexa Fluor 488) through the PCE. (C) Representative monosynaptic eEPSCs 730 
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evoked consecutively by stimulating the DR (100 μA, 1 ms, 10 sweeps) while holding the 731 
neuron’s membrane potential (VH) at -70 mV (Materials and Methods). The average trace is 732 
shown in black. (D) Histogram of eEPSC’s peak amplitudes. The stimulus intensity ranged 733 
between 100 – 600 μA. (E) Consecutive eEPSCs recorded before and after exposing the spinal 734 
cord to 1 μM CNQX (averages are displayed in black and red, respectively). (F). Spontaneous 735 
glutamatergic synaptic currents at VH = -70 mV before (black) and after (red) exposure to 1 μM 736 
CNQX. 737 
 738 
Figure 4. Spiking examples from neurons in the superficial dorsal horn. (A) Subthreshold 739 
and suprathreshold responses evoked by a stimulus of 100 μA. (B) Pair of action potentials 740 
exhibiting an afterdepolarization. This response was evoked by a brief 0.5 ms stimulus. (C) 741 
Spontaneous spiking (RMP = -62 mV). (D) Recording of passive and active responses evoked by 742 
sustained current injection (-20 pA-30 pA). First active trace shown in red.   743 
 744 
Figure 5. eEPSCs from superficial dorsal horn neurons are potentiated by submillimolar 745 
concentrations of TEA and 4-AP. (A) and (B) Left and center: Consecutive monosynaptic 746 
eEPSCs recorded before and after (15-20 sweeps) exposing the spinal cord to 50 μM 4-AP (A) 747 
and 500 μM TEA (B). Averages displayed in red. Right:  pooled paired measurements of peak 748 
EPSCs before (control) and after exposure to 4-AP (A) and TEA (B) with box plots showing the 749 
percent change in peaks across paired experiments. Sample size and p values of the paired 750 
Student t-test are shown on the graphs. Stimulation parameters are as indicated in Fig. 2 legend 751 
and Materials and Methods. Each symbol in the graphs represents an independent response from 752 
a separate spinal cord (i.e., the sample size corresponds to number of animals examined). Percent 753 
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change box plots describe the data sets as follows: dashed and solid lines representing mean and 754 
median, respectively; lower and upper edges of the box corresponding to 25 and 75 percentiles, 755 
respectively; lower and upper whiskers corresponding to 5 and 95 percentiles, respectively; and 756 
crosses representing minimum and maximum values. 757 
 758 
Figure 6. eEPSCs from superficial dorsal horn neurons are not affected by specific 759 
inhibitors of Kv7, BK and Kv1 channels. (A) – (C). Left and center: Consecutive 760 
monosynaptic eEPSCs recorded before and after (2-30 sweeps) exposing the spinal cord to the 761 
indicated K+ channel inhibitors (XE991, IbTX, and α-DTX). Averages displayed in red. Right:  762 
pooled paired measurements of peak EPSCs before (control) and after exposure to the indicated 763 
inhibitors. Sample size and P values of the paired Student t-test are shown on the graphs. 764 
Stimulation parameters are as indicated in Fig. 2 legend and Materials and Methods. Each 765 
symbol in the graphs represents an independent response from a separate spinal cord (i.e., the 766 
sample size corresponds to number of animals examined). Percent change box plots are 767 
displayed to the right of summary data plots (Fig. 5 legend describes box plot characteristics). 768 
 769 
Figure 7. Determination of monosynaptic responses from individual eEPSC traces. 770 
Representative eEPSC traces from examples displayed in Fig. 5 demonstrating consistent 771 
monosynaptic peaks across multiple traces (dashed red lines). The by-eye identification of the 772 
peaks in individual traces was generally confirmed by determining the regions of the average 773 
trace with the lowest variance around the average peak. The magnitude of these peaks was used 774 
for the analysis of monosynaptic eEPSCs in Fig. 8. 775 
 776 
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Figure 8. Submillimolar 4-AP and TEA consistently potentiate monosynaptic EPSCs. 777 
Pooled paired average peaks from the multi-peak analysis (Fig. 7) before and after exposure to 778 
50 μM 4-AP (A), 500 μM TEA (B), 100 nM IbTX (C), 30 μM XE991 (D), and 80 nM ?-DTX 779 
(E). Color scheme displays the numerical order of peaks in a given recording (light grey = 1st 780 
peak, dark grey = 2nd peak, light blue = 3rd peak, dark blue = 4th peak, light pink = 5th peak, dark 781 
pink = 6th peak, averages shown in red). The p values of the paired Student t-test are shown on 782 
the graphs. Percent change box plots are displayed to the right of summary data plots (Fig. 5 783 
legend describes box plot characteristics). 784 
 785 
Figure 9. Submillimolar 4-AP and TEA decrease the paired pulse ratio (PPR). (A) and (B) 786 
Paired pulse (interstimulus interval = 30-80 ms) EPSC recordings before and after (10 sweeps) 787 
exposing the spinal cord to 50 μM 4-AP (A) and 500 μM TEA (B).  Right:  pooled paired 788 
measurements of the paired pulse ratio (PPR = P2/P1) before (control) and after exposure to 4-789 
AP (A) and TEA (B). Sample size and p values of the paired Student t-test are shown on the 790 
graphs. All recordings were conducted at VH = -70 mV. Stimulation parameters are as indicated 791 
in Fig. 2 legend and Materials and Methods. Each symbol in the graphs represents an 792 
independent response from a separate spinal cord (i.e., the sample size corresponds to number of 793 
animals examined). 794 
 795 
Figure 10. Submillimolar TEA does not affect spontaneous EPSCs. (A) Representative 796 
sweeps of sEPSCs at -70 mV, before and after exposing the spinal cord to 500 μM TEA (left and 797 
right, respectively). Zoomed-in segments are also shown to demonstrate individual events. (B) 798 
Relative frequency histograms of peak EPSC amplitudes from three independent recordings 799 
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(three neurons each from three different spinal cords) before and after exposure to TEA. Relative 800 
frequency is the fraction of sEPSCs that falls into a given bin (bin size = 0.75 pA). (C) 801 
Cumulative plots of sEPSC amplitudes corresponding to the data shown in panel B. In all three 802 
cases, the two-sample Kolmogorov-Smirnov test returned no difference between the control and 803 
TEA plots. The p values are indicated on the plots. 804 
 805 
Figure 11. Analysis of the primary nociceptor action potentials in the absence and presence 806 
of several K+ channel inhibitors. Left to right: Representative action potential traces, phase 807 
plane plots, and changes in APD50, APD90, and maximum repolarization rate (derived from phase 808 
plane plots) before and after exposure to 50 μM 4-AP (A), 500 μM TEA (B), 100 nM IbTX (C), 809 
30 μM XE991 (D), and 80 nM ?-DTX (E). Averages shown in black and p values of the paired 810 
Student’s t test are displayed on graphs. Additional properties are reported on Table 4. 811 
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Table 1. EPSC Properties 
 
 n 
Peak (pA) 272.39 ± 31.57 79 
Rise Time (ms) 7.89 ± 0.65 79 
Latency (ms) 21.19 ± 0.65 79 
Jitter (ms) 1.63 ± 0.17 75 
 
Peak calculated as the amplitude of the EPSC waveform. 
Rise Time calculated as the time from 10% to 90% of the EPSC 
waveform. 
Latency calculated as the time from the start of the stimulus to the 
peak amplitude. 
Jitter calculated as the time variability in the start of the EPSC 
waveform across multiple traces. 
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Table 2. Passive and Active Properties of Second Order Dorsal Horn Neurons 
 
                           n 
RMP (mV) -74 ± 0.88 65 
Input Resistance (GΩ) 0.95 ± 0.07 53 
Capacitance (pF) 37.56 ± 3.84 37 
Threshold (mV) -55.65 ± 0.77 40 
AP Amplitude (mV) 96.6 ± 1.81 40 
ADP Amplitude (mV) 7.69 ± 0.7 24 
AHP (mV) -76.79 ± 1.21 16 
APD50 (ms) 1.86 ± 0.09 40 
APD90 (ms) 0.68 ± 0.03 40 
Max depolarization rate (mV ms-1) 142.09 ± 8.29 40 
Max repolarization rate (mV ms-1) 60.24 ± 4.01 40 
 
RMP = Resting Membrane Potential; AP = Action Potential; ADP = Afterdepolarization; AHP = 
Afterhyperpolarization; APD50 = Action Potential Duration at 50% of the Amplitude; APD90 = 
Action Potential Duration at 90% of the Amplitude 
 
AP Amplitude calculated as the difference from the most negative membrane potential to the most 
positive membrane potential during an AP waveform. 
ADP Amplitude calculated from the most negative membrane potential to the peak of the ADP. 
Max depolarization and repolarization rates determined from the derivative of the AP waveform. 
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Table 3. Effects of Pharmacological Compounds on EPSC Properties 
 
  
500 μM TEA 
 
 
50 μM 4-AP 
 
100 nM IbTX 
 
30 μM XE991 
 
80 nM DTX 
  
Pre 
 
 
Post 
 
Pre 
 
Post 
 
Pre 
 
Post 
 
Pre 
 
Post 
 
Pre 
 
Post 
 
Peak (pA) 
 
323.91 ± 
121.32 
 
370.27 ± 
123.30* 
 
193.91 ± 
43.69 
 
258.21 ± 
49.75** 
 
473.19 ± 
178.68 
 
502.68 ± 
191.33 
 
367.66 ± 
85.29 
 
322.93 ± 
123.56 
 
470.52 ± 
203.08 
 
461.1 ± 
179.54 
 
Rise Time 
(ms) 
 
8.59 ± 1.60 
 
9.81 ± 1.69 
 
8.45 ± 2.00 
 
7.96 ± 1.44 
 
9.23 ± 3.27 
 
8.48 ± 2.85 
 
13.75 ± 3.17 
 
13.05 ± 3.25 
 
7.34 ± 2.23 
 
7.35 ± 2.24 
 
Latency 
(ms) 
 
20.27 ± 2.34 
 
20.45 ± 2.41 
 
22.44 ± 3.06 
 
22.77 ± 3.31 
 
22.07 ± 4.15 
 
21.63 ± 3.98 
 
25.15 ± 4.32 
 
25.99 ± 4.80 
 
21.31 ± 5.71 
 
21.60 ± 5.61 
 
Jitter (ms) 
 
1.66 ± 0.36 
 
1.71 ± 0.31 
 
2.07 ± 0.73 
 
1.56 ± 0.45 
 
1.8 ± 0.38 
 
1.6 ± 0.52 
 
2.83 ± 1.03 
 
3.58 ± 1.29 
 
1.38 ± 0.58 
 
2.05 ± 0.80 
 
n 
 
9 
 
7 
 
8 
 
5 
 
4 
 
Peak is the maximum amplitude of the EPSC waveform. 
Rise Time calculated as the time from 10% to 90% of the EPSC waveform. 
Latency calculated as the time from the start of the stimulus to the peak amplitude. 
Jitter calculated as the time variability in the start of the EPSC waveform across multiple traces. 
 
* p ≤ 0.05; ** p ≤ 0.01 
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Table 4. Effects of Pharmacological Compounds on the DRG Action Potential 
 
 
 
500 μM TEA 
 
 
50 μM 4-AP 
 
100 nM IbTX 
 
30 μM XE991 
 
80 nM DTX 
 
 
Pre 
 
 
Post 
 
Pre 
 
Post 
 
Pre 
 
Post 
 
Pre 
 
Post 
 
Pre 
 
Post 
 
Capacitance 
(pF) 
 
12.88 ± 
1.20 
 
  16.07 ± 
4.52 
  13.83 ± 
1.46 
  12.75 ± 
1.47 
  12.73 ± 
1.11 
 
 
Diameter 
(μm) 
 
21.61 ± 
0.93 
 
  20.78 ± 
0.97 
  21.25 ± 
1.02 
  21.43 ± 
0.88 
  20.47 ± 
0.97 
 
 
 
RMP (mV) 
 
-62.36 ± 
4.42 
 
 
-65.50 ± 
6.07 
 
-67.25 ± 
2.30 
 
-71.50 ± 
2.75* 
 
-66.93 ± 
2.90 
 
-70.79 ± 
3.67** 
 
-66.07 ± 
2.45 
 
-64.93 ± 
2.52 
 
-64.88 ± 
3.05 
 
-69.88 ± 
4.56 
 
 
IR (GΩ) 
 
0.55 ± 
0.16 
 
 
0.77 ± 
0.19 
 
1.06 ± 
0.32 
 
1.38 ± 
0.33 
 
0.76 ± 
0.19 
 
0.92 ± 
0.23 
 
0.93 ± 
0.17 
 
1.39 ± 
0.29 
 
0.89 ± 
0.17 
 
1.05 ± 
0.15 
 
Threshold 
(mV) 
 
-29.21 ± 
3.04 
 
 
-32.64 ± 
4.23 
 
-28.63 ± 
2.08 
 
-31.88 ± 
2.60* 
 
-26.36 ± 
3.82 
 
-29.21 ± 
4.31* 
 
-29.07 ± 
1.81 
 
-30.36 ± 
1.65 
 
-29.88 ± 
2.60 
 
-35.00 ± 
2.05* 
 
Amplitude 
(mV) 
 
113.05 ± 
2.93 
 
 
111.91 ± 
4.63 
 
115.47 ± 
2.41 
 
116.98 ± 
3.86 
 
108.08 ± 
4.96 
 
110.23 ± 
6.26 
 
109.97 ± 
3.98 
 
107.89 ± 
3.24 
 
110.79 ± 
4.55 
 
107.27 ± 
5.39 
 
AHP (mV) 
 
-73.47 ± 
2.35 
 
 
-74.49 ± 
5.45 
 
-73.11 ± 
1.54 
 
-75.68 ± 
2.14 
 
-72.36 ± 
2.24 
 
-76.85 ± 
3.01* 
 
-73.32 ± 
2.48 
 
-73.35 ± 
2.11 
 
-71.63 ± 
1.91 
 
-76.34 ± 
2.35 
 
APD50
 (ms) 
 
4.33 ± 
0.63 
 
 
7.60 ± 
1.27** 
 
4.43 ± 
0.47 
 
6.28 ± 
0.83* 
 
4.15 ± 
0.48 
 
5.46 ± 
0.90* 
 
4.73 ± 
0.53 
 
5.16 ± 
0.62 
 
3.80 ± 
0.43 
 
3.67 ± 
0.50 
 
APD90 (ms) 
 
1.04 ± 
0.05 
 
 
1.30 ± 
0.06*** 
 
1.09 ± 
0.07 
 
1.40 ± 
0.11* 
 
1.05 ± 
0.05 
 
1.17 ± 
0.10 
 
1.13 ± 
0.06 
 
1.15 ± 
0.07 
 
1.05 ± 
0.07 
 
1.05 ± 
0.09 
 
Max 
depolarization 
Rate (mV/ms) 
 
 
79.84 ± 
17.67 
 
79.35 ± 
21.17 
 
75.42 ± 
8.83 
 
69.75 ± 
8.76 
 
68.26 ± 
10.93 
 
67.01 ± 
11.73 
 
61.28 ± 
8.94 
 
55.55 ± 
6.12 
 
77.82 ± 
12.72 
 
71.50 ± 
11.87 
 
Max 
repolarization 
Rate (mV/ms) 
 
 
38.37 ± 
3.68 
 
25.04 ± 
2.30*** 
 
33.90 ± 
2.64 
 
25.94 ± 
2.66* 
 
37.99 ± 
3.81 
 
35.13 ± 
4.95 
 
35.38 ± 
3.75 
 
32.76 ± 
2.91 
 
38.04 ± 
3.15 
 
40.65 ± 
4.17 
 
n 
 
7 
 
 
8 
 
7 
 
7 
 
8 
 
  2 
 RMP = Resting membrane potential, AHP = Afterhyperpolarization, APD50 = Action potential duration at 50% of amplitude, APD90 = Action 
potential duration at 90% of amplitude     * p < 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
 











